Foresee Pharmaceuticals Is A Biopharmaceutical Company Based In Taiwan And The United Statespublicly Listed On The Taipei Exchangethe Company Is Committed To Addressing Global Health Needs By Advancing Pharmaceutical Science And Developing Innovative Treatmentsforesee Focuses On Challenging Traditional Drug Development Methods To Enhance Patient Care And Operates Globally Through Partnerships That Facilitate The Commercialization Of Both Development Stage And Approved Products The Company S Research And Development Efforts Are Centered On Two Main Areasstabilized Injectable Formulations And New Chemical Entitiestheir Pipeline Includes Candidates Targeting Neurologicalpsychiatricrespiratoryand Inflammatory Diseasesnotable Products In Development Include Fp 017 For Neurological And Psychiatric Conditionsand Several Mmp 12 Inhibitors Aimed At Treating Asthmachronic Obstructive Pulmonary Diseaseand Interstitial Lung Diseaseforesee Pharmaceuticals Aims To Improve Drug Delivery And Patient Compliance While Expanding Its Reach Through Strategic Collaborations In Various International Markets
